We are live on ! Find out more
CG

Cutler Group Portfolio holdings

AUM $307M Turnover 51.18%
1-Year Est. Return 45.11%
This Fund
S&P 500
This Quarter Est. Return
+17.17%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.48%
10 Year Est. Return
–
AUM
$307M
AUM Growth
-$811M
Cap. Flow
-$553M
Cap. Flow %
-179.89%
Top 10 Hldgs %
17.31%
Holding
3,982
New
287
Increased
211
Reduced
1,652
Closed
1,751
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 66.85%
2 Technology 10.21%
3 Consumer Discretionary 5.9%
4 Healthcare 3.3%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DCFC
3926
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
– –
-1
Closed – –
EIGR
3927
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-33
Closed – –
CPE
3928
CALL
DELISTED
Callon Petroleum Company
CPE
– –
-38,700
Closed -$16K –
JOAN
3929
DELISTED
JOANN, Inc. Common Stock
JOAN
– –
-18,707
Closed -$8K –
FSR
3930
CALL
DELISTED
Fisker Inc.
FSR
– –
-233,800
Closed -$14K –
FSR
3931
DELISTED
Fisker Inc.
FSR
– –
-8,257
Closed -$14K –
FSR
3932
PUT
DELISTED
Fisker Inc.
FSR
– –
-284,700
Closed -$905K –
CBAY icon
3933
CALL
DELISTED
Cymabay Therapeutics
CBAY
– –
-10,000
Closed -$23K –
ADOCW
3934
DELISTED
Edoc Acquisition Corp. Warrant
ADOCW
– –
-300
Closed – –
AYX
3935
CALL
DELISTED
Alteryx Inc
AYX
– –
-26,000
Closed -$113K –
AYX
3936
DELISTED
Alteryx Inc
AYX
– –
-9,780
Closed -$461K –
KRTX icon
3937
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-700
Closed -$63K –
KRTX icon
3938
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-300
Closed -$94K –
SPLK icon
3939
CALL
DELISTED
Splunk Inc
SPLK
– –
-39,900
Closed -$209K –
SPLK icon
3940
DELISTED
Splunk Inc
SPLK
– –
-1,524
Closed -$232K –
SPLK icon
3941
PUT
DELISTED
Splunk Inc
SPLK
– –
-14,900
Closed -$1K –
FAZE
3942
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
– –
-344
Closed – –
AMAM
3943
CALL
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-300
Closed -$1K –
AMAM
3944
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-2,380
Closed -$33K –
AMAM
3945
PUT
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-100
Closed -$1K –
BFX
3946
DELISTED
BowFlex Inc.
BFX
– –
-42
Closed – –
CRGE
3947
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
– –
-300
Closed – –
ROVR icon
3948
CALL
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
– –
-1,100
Closed -$5K –
THCX
3949
DELISTED
AXS Cannabis ETF
THCX
– –
-10
Closed – –
ICVX
3950
DELISTED
Icosavax, Inc. Common Stock
ICVX
– –
-500
Closed -$7K –

Similar funds

Cutler Group's Q1 2024 Portfolio in Review

As of Q1 2024, Cutler Group held 3,982 positions worth $307M, down 73% from $1.12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cutler Group withdrew a net $553M in Q1 2024, closing 1,751 positions and reducing 1,652 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cutler Group opened a new position in iShares S&P 500 Growth ETF worth $7.85M.

  • Cutler Group's largest Q1 2024 buy was iShares S&P 500 Growth ETF: 93,001 shares worth $7.85M.
  • Cutler Group added most to ProShares Ultra QQQ in Q1 2024, an estimated $2.3M increase.
  • Cutler Group's biggest Q1 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $25M.
  • Cutler Group fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2024, selling an estimated $17.8M.
  • Cutler Group's ten largest holdings make up 17% of its $307M portfolio in Q1 2024.
  • Cutler Group opened 287 new positions and closed 1,751 in Q1 2024.
  • Cutler Group's portfolio value fell 73% quarter-over-quarter to $307M.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.